Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.14.5 extracted from

  • Ikuma, Y.; Hochigai, H.; Kimura, H.; Nunami, N.; Kobayashi, T.; Uchiyama, K.; Umezome, T.; Sakurai, Y.; Sawada, N.; Tadano, J.; Sugaru, E.; Ono, M.; Hirose, Y.; Nakahira, H.
    Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors: Use of a carboxylate prodrug to improve bioavailability (2015), Bioorg. Med. Chem., 23, 779-790.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-[(3R)-3-aminopiperidin-1-yl]-3-(2-chlorobenzyl)-5-methyl-4-oxo-4,5-dihydro-3H-imidazo[4,5-c]quinoline-8-carboxylate compound shows significantly high oral absorption and potent dipeptidyl peptidase IV inhibition in vivo and decreased Zucker fatty rats glucose levels in the oral glucose tolerance test Rattus norvegicus
3H-imidazo[4,5-c]quinolin-4(5H)-one inhibitor with potent dipeptidyl peptidase IV inhibitory activity that shows poor oral absorption can be improved by esterification of the carboxylic acid moiety Rattus norvegicus

Organism

Organism UniProt Comment Textmining
Rattus norvegicus
-
-
-